Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gulfstream Life Sciences is a medical technology company that specializes in regenerative medicine and biologics for the orthopedic and spinal surgery markets. The company develops and distributes a comprehensive portfolio of bone graft substitutes, including xenografts, allografts, and amniotic-derived tissues. Their flagship products, such as G-Graft and G-Cell, are designed to provide osteoconductive and osteoinductive properties to facilitate bone healing and successful surgical fusion. Gulfstream focuses on delivering high-quality, clinically effective solutions to surgeons and healthcare facilities to improve patient outcomes in musculoskeletal care. The company's business model emphasizes providing cost-effective alternatives to traditional biologic products without compromising clinical efficacy. Headquartered in Florida, Gulfstream serves a wide network of hospitals and ambulatory surgery centers across the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gulfstream Life Science.